RAS inhibitors

1 entry tagged RAS inhibitors. All writing.

SEPTEMBER 17, 2026 Pancreatic Cancer Has a Drug That Works. Now the FDA Wants It Tried First Three weeks after approving daraxonrasib for pancreatic cancer that has already been treated — the first drug to roughly double survival in that disease — the FDA gave it Breakthrough Therapy status for newly diagnosed patients, on top of chemotherapy. What the drug does, what the trials actually showed, what "breakthrough" legally means, and the $39,800-a-month company behind it.

Medical disclaimer. Everything on this site is general information for education only. It is not medical, nutritional or health advice, and it is not a substitute for advice from a licensed physician, pharmacist, dietitian or other qualified health professional who knows you. The author is not a licensed health professional and writes under a pen name; no entry has been reviewed by a doctor or anyone else with a medical licence. Reading this site, or writing to it, creates no doctor–patient or other professional relationship. Do not start, stop or change any medication, supplement, diet or treatment because of something read here — talk to your clinician first. If you think you may have a medical emergency, call your doctor or your local emergency number (911 in the United States) now. Read the full disclaimer →